This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Monto, A S Articles by Maassab, H F Search for Related Content PubMed PubMed Citation Articles by Monto, A S Articles by Maassab, H F

 Previous Article  |  Next Article 

J Clin Microbiol. 1981 January; 13(1): 54-57

Ether treatment of type B influenza virus antigen for the hemagglutination inhibition test.

ABSTRACT

Ether treatment was studied as a method of increasing the ability of type B influenza antigen to detect antibody by hemagglutination inhibition. Comparisons were made with the untreated antigen, with an eluate made from the same virus, and with a standard type B antigen of an earlier virus. Results were evaluated based on the comparative ability to detect rises in antibody titer, as well as the relative frequency of antibody prevalence determined by each method. The ether-treated antigen was far superior to the untreated antigen in both respects; it was also superior to the eluate, although the difference was less pronounced. The treated antigen performed better than the standard type B antigen in detecting antibody in children, but there was little difference in adults. This pattern was felt to be a result of the closer relation of the treated antigen to the infecting strain. The method is, therefore, proposed as a means of producing more reactive antigens of currently circulating strains of type B influenza virus.